[Effects of inhibitors of the angiotensin-converting enzyme on endothelial dysfunction in patients with stable angina pectoris].
The article focuses on the antiatherosclerotic and antiischemic potential of inhibitors of the angiotensin-converting enzyme and discusses the issue of their administration in those patients with ischemic heart disease presenting with no disorders in the function of the left ventricle. The studies under way, Simvastatin Coronary' Atherosclerosis Trial (SCAT), Prevention of Atherosclerosis Risk and Thrombosis (PART-2) among them, will, we believe, help in answering the question.